Results 11 to 20 of about 6,229,024 (291)

Quantification of thermal dose in moderate clinical hyperthermia with radiotherapy: a relook using temperature–time area under the curve (AUC)

open access: yesInternational Journal of Hyperthermia, 2021
Background Thermal dose in clinical hyperthermia reported as cumulative equivalent minutes (CEM) at 43 °C (CEM43) and its variants are based on direct thermal cytotoxicity assuming Arrhenius ‘break’ at 43 °C.
Niloy R. Datta   +11 more
doaj   +2 more sources

ADJUVANT CHEMORADIOTHERAPY WITH LOCAL HYPERTHERMIA IN COMBINED TREATMENT OF PRIMARY GLIOBLASTOMA: PRELIMINARY RESULTS [PDF]

open access: yesСибирский онкологический журнал, 2017
A new technique of concurrent chemoradiotherapy and local electromagnetic hyperthermia for treatment of patients with newly diagnosed glioblastoma was developed at the Cancer Research Institute of Tomsk National Research Medical Center.
A. I. Ryabova   +5 more
doaj   +2 more sources

ROLE OF LOCAL HYPERTHERMIA IN COMBINED MODALITY TREATMENT OF SOFT TISSUE SARCOMAS

open access: yesСибирский онкологический журнал, 2016
The review aimed to assess the role of local hyperthermia in combined modality treatment of soft tissue sarcoma. The recent randomized trials have shown significant benefits from local hyperthermia in patients with soft tissue sarcoma. When combined with
Zh. A. Startseva   +8 more
doaj   +1 more source

Dermatologic indications for microwave-induced local hyperthermia

open access: yesJournal of Dermatological Treatment
Objectives The potential utility of a novel microwave device for the treatment of a variety of superficial dermatologic indications is reviewed.Materials and methods The Swift® microwave system applies low-dose microwave energy (8 GHz) noninvasively ...
Aditya K. Gupta   +3 more
doaj   +3 more sources

LOCAL HYPERTHERMIA IN COMBINED MODALITY TREATMENT OF LARYNGEAL AND LARYNGOPHARYNGEAL CANCER

open access: yesСибирский онкологический журнал, 2016
Preliminary treatment outcomes for 35 patients with stage T1–3N0–2M0 laryngeal and laryngopharyngeal cancer have been presented. Out of 35 patients, there were 30 with laryngeal cancer and 5 with laryngopharyngeal cancer.
Е. L. Choynzonov   +7 more
doaj   +1 more source

Local Hyperthermia Combined With Imiquimod Cleared Recalcitrant and Extensive Warts in a Patient With Systemic Lupus Erythematosus. [PDF]

open access: yesClin Cosmet Investig Dermatol
Gai-Hua Wang,1,* Yang-Bin Wang,2,3,* Yue-Ai Cheng,1 Hong-Duo Chen,2,3 Xing-Hua Gao,2,3 Rui-Qun Qi2,3 1Institute of Dermatology, Taiyuan City Centre Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, People’s Republic of China ...
Wang GH   +5 more
europepmc   +2 more sources

Hyperthermia for locally advanced breast cancer [PDF]

open access: yesInternational Journal of Hyperthermia, 2010
Hyperthermia (HT) has a proven benefit for treating superficial malignancies, particularly chest wall recurrences of breast cancer. There has been less research utilising HT in patients with locally advanced breast cancer (LABC), but available data are promising.
Timothy M, Zagar   +7 more
openaire   +2 more sources

Hyperthermia-triggered Biomimetic Bubble Nanomachines

open access: yes, 2023
Source data for Hyperthermia-triggered Biomimetic Bubble ...
Fei Peng (16667272)   +10 more
core   +1 more source

Ifosfamide with regional hyperthermia in soft-tissue sarcomas [PDF]

open access: yes, 2003
For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve outcome with regard to local control and overall survival.
M. Schlemmer   +5 more
core   +1 more source

Hyperthermia combined with chemotherapy - Biological rationale, clinical application, and treatment results [PDF]

open access: yes, 1999
There is substantial evidence from preclinical data that the antitumor cytotoxicity of selected chemotherapeutic agents either alone or combined with radiation can be enhanced by appropriate heat exposure (40-44 degrees C) of cells or tumor tissues ...
Issels, R.D., Issels, Rolf-Dieter
core   +1 more source

Home - About - Disclaimer - Privacy